Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Confirmation Biases

Confirmation Biases

The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias?

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Follitropin alfa biosimilars: unfounded doubts on the road to reproductive care.

Human reproduction (Oxford, England)·2025

Same author

An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study.

JMIR formative research·2024

Same author

Transgenic mice overexpressing the PGE<sub>2</sub> receptor EP<sub>2</sub> on mast cells exhibit a protective phenotype in a model of allergic asthma.

Allergy·2021

Same author

<i>In Vitro</i> and <i>In Vivo</i> Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity.

Allergy, asthma & immunology research·2020

Same author

Biosimilar and interchangeable: Inseparable scientific concepts?

British journal of clinical pharmacology·2019

Same author

Biosimilar: what it is not.

British journal of clinical pharmacology·2015

Same journal

Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 23, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Biosimilars: A Value Proposition.

Fernando de Mora¹

¹Department of Pharmacology, Therapeutics, and Toxicology, Universidad Autónoma de Barcelona, Barcelona, Spain. fernando.demora@uab.cat.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy

|June 9, 2019

Summary

This summary is machine-generated.

Biosimilars increase patient access to treatments and foster innovation. However, pricing challenges can hinder their adoption, impacting healthcare sustainability and patient benefits.

More Related Videos

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Related Experiment Videos

Last Updated: Jan 23, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

Area of Science:

Pharmaceutical Sciences
Health Economics

Background:

Biosimilars are highly similar biological products to existing reference biologics.
Their development aims to increase market competition and healthcare system sustainability.
Biosimilars can reduce treatment costs and improve patient access to therapies.

Purpose of the Study:

To analyze the economic impact and market dynamics of biosimilars.
To explore how pricing strategies affect biosimilar adoption and healthcare sustainability.

Main Methods:

Literature review on biosimilar market entry and pricing.
Economic analysis of healthcare system impacts.
Assessment of physician prescribing behaviors.

Main Results:

Biosimilars offer significant cost savings and enhance patient access to biologics.
Harmonized pricing between reference biologics and biosimilars can deter physician prescribing.
Unfavorable market conditions limit the full potential and value of biosimilars.

Conclusions:

Equitable pricing strategies are crucial for successful biosimilar market integration.
Addressing market dynamics is essential to ensure the viability of healthcare services.
Optimizing biosimilar offerings maximizes patient benefits and healthcare sustainability.